Bio-Techne Corporation ( NASDAQ:TECH ) shareholders might be concerned after seeing the share price drop 17% in ...

Zurcher Kantonalbank Zurich Cantonalbank decreased its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 2.8% in the 4th quarter, according to the company in its most recent Form 13F ...

Keybank National Association OH boosted its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 66.4% in the ...

Exosomes Market Exosomes Market is estimated to be valued at USD 222.1 Mn in 2025 and is expected to reach USD 1,284.1 Mn by 2032, exhibiti ...

DelveInsight's In Situ Hybridization Market Insights report provides the current and forecast market analysis, individual ...

The demand for in situ hybridization is experiencing significant growth, mainly due to the rising rates of cancer and genetic disorders. This trend is further driven by the increasing incidence ...

The $40m tower proposal was granted a planning permit by the Hobart City Council last year and the proponent, Techne Invest, which counts former AFL star Nick Riewoldt as one of its directors ...

Investopedia / Paige McLaughlin Ltd. is a standard abbreviation for "limited," a form of corporate structure available in members of the Commonwealth, including the U.K., Ireland, and Canada.

Bengaluru: Indorama Ventures Europe (IVE) will acquire a minority stake of about 24.9% in EPL Limited, a global specialty packaging company and manufacturer of laminated tubes, from private equity ...

Bio-Techne Corp. TECH recently launched an expanded menu of human and mouse RNAscope in situ hybridization probes to advance spatial biology research and the development of next-generation ...

The shares have sprung back to life thanks to China’s new stimulus programs—and Alibaba’s AI ventures. They stand to gain as much as 48%.